Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2014 Annual Report

2014 Proxy Statement

2013 Annual Report

2013 Proxy Statement

2012 Annual Report

2011 Annual Report

2012 Proxy Statement


Recent Releases

May 5, 2015
GenMark Diagnostics Reports Q1 Financial Results

Apr 29, 2015
GenMark Diagnostics to Present at Bank of America Merrill Lynch 2015 Health Care Conference

View all releases »

Events

May 13, 2015 at 3:00 PM PT
Bank of America Merrill Lynch 2015 Health Care Conference

May 5, 2015 at 4:30 PM ET
GenMark Diagnostics First Quarter Earnings Conference Call

View all events »

Related Links

Stock Quote
Price:
9.04
Change:
+ 0.01
Day High:
9.18
Day Low:
8.99
Volume:
183,300
NASDAQ
GNMK
4:00 PM ET on May 22, 2015
Delayed at least 20 minutes.
Provided by eSignal.